Applied DNA Sciences, Inc. | Finanzwire

Basculer en Français

9478	Companies
185492	Keywords
117871	Articles
99349	Press releases

Headlines Articles Press releases Applied DNA Sciences, Inc.

Home
Companies
Applied DNA Sciences, Inc.

BRIEF

published on 05/10/2024 at 15:05, 1 year 6 months ago

Applied DNA Sciences Regains Compliance with Nasdaq's Minimum Bid Price Rule

Nasdaq Compliance Stock Market Applied DNA Sciences Financial Regulations PCR-based DNA
PRESS RELEASE

published on 05/10/2024 at 15:00, 1 year 6 months ago

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Applied DNA Sciences regains compliance with Nasdaq's minimum bid price requirement. The company's ordinary shares closed above $1.00 for 10 consecutive business days

Compliance Nasdaq Applied DNA Sciences Minimum Bid Price PCR-based DNA Technologies
BRIEF

published on 04/25/2024 at 15:05, 1 year 7 months ago

Applied DNA Sciences, Inc. Partners with HDT Bio to Enhance Rapid Vaccine Production

Applied DNA Sciences HDT Bio Rapid Vaccine Development PCR-based DNA Technologies Decentralized Manufacturing
PRESS RELEASE

published on 04/25/2024 at 15:00, 1 year 7 months ago

Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
Applied DNA Sciences, Inc. receives contract from HDT Bio to demonstrate rapid manufacturing of mRNA vaccines in 7 days, utilizing Linea DNA and Linea IVT platforms

Manufacturing Applied DNA Sciences MRNA Vaccines Vaccine Development HDT Bio
BRIEF

published on 04/22/2024 at 22:10, 1 year 7 months ago

Applied DNA Announces 1-For-20 Reverse Stock Split

Share Consolidation Reverse Stock Split Applied DNA Sciences NASDAQ:APDN Equity Adjustment
PRESS RELEASE

published on 04/22/2024 at 22:05, 1 year 7 months ago

Applied DNA Announces 1-For-20 Reverse Stock Split
Applied DNA Sciences, Inc. (NASDAQ:APDN) announces 1-for-20 stock split effective April 25, 2024, to regain Nasdaq listing compliance. Proportional adjustments made. For more information, visit adnas.com

Nasdaq Applied DNA Sciences Stock Split Nasdaq Listing Compliance Proportional Adjustments
BRIEF

published on 03/18/2024 at 14:05, 1 year 8 months ago

Applied DNA Sciences Partners with Alphazyme to Scale-Up Manufacturing of Linea™ RNAP

Applied DNA Sciences Alphazyme Linea RNAP MRNA Manufacturing PCR Technology
PRESS RELEASE

published on 03/18/2024 at 14:00, 1 year 8 months ago

Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
Applied DNA Sciences and Alphazyme LLC collaborate to enhance manufacturing of Linea RNA polymerase to meet growing demand for Linea IVT platform. Project aims to increase RNAP manufacturing capacity and reduce unit costs

Manufacturing Applied DNA Sciences Linea IVT Platform Alphazyme LLC Linea RNA Polymerase
BRIEF

published on 03/14/2024 at 15:05, 1 year 8 months ago

Applied DNA to Present Advanced DNA Platforms at World Vaccine Congress

Applied DNA Sciences World Vaccine Congress Linea DNA Platform Linea IVT Platform MRNA Production
PRESS RELEASE

published on 03/14/2024 at 15:00, 1 year 8 months ago

Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress
Applied DNA Sciences, Inc. will showcase Linea™ IVT and Linea™ DNA platforms at the 24th Annual World Vaccine Congress in Washington, D.C. Sales team available

Applied DNA Sciences DNA Technologies World Vaccine Congress Linea DNA Linea IVT

Accesswire

Published on 12/05/2025 at 16:00, 37 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 52 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 1 hour 2 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 1 hour 12 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 1 hour 37 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 16:25, 12 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 27 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 37 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 37 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 37 minutes ago

Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 15:10, 1 hour 27 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 7 hours 52 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 22 hours 37 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 22 hours 52 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 22 hours 53 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

View all LES ECHOS COMFI WIRE